Good news for travellers, SII's Adar Poonawalla after 16 European countries recognise Covishield

New Delhi: In a boost to Serum Institute of India (SII), 16 European countries have now recognised and accepted Oxford-Astrazeneca vaccine for entry of international travellers.

Sharing the news on Twitter, SII CEO Adar Poonawalla stated, “It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for entry. However, despite being vaccinated, entry guidelines might vary from country to country, so do read up before you travel.”

France is the latest addition in the list of European nations that recognises the Covishield vaccine, thus lifting travel restrictions for fully vaccinated travellers. The other European nation that have recognised Covishield vaccine as proof of immunisation for travel includes Austria, Belgium, Bulgaria, Finland, Germany, Greece, Hungary, Iceland, Ireland, Latvia, the Netherlands, Slovenia, Spain, Sweden, Switzerland.

The issue of the acceptance of the Covishield vaccine as proof of immunisation for travel to the EU Member States has been widely discussed recently, after several countries in the block have refused to recognise the vaccine.